TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07629557: Single-arm, Multi-center Study to Evaluate the Safety and Feasibility of Bilateral Epithelium-on Corneal Collagen Cross-linking With Epioxa™ HD/Epioxa™ and UV-A Irradiation Using the O2n™ System and Supplemental Oxygen U

Sponsor: Glaukos Corporation · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$743,680

Rescue Site Savings

+$478,080

Unlock Full NCT07629557 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07629557 Rescue Dossier →